| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.32 | 0.03 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.03 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.03 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.13 | 0.03 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.04 |